Rite Aid surges after 2015 sales forecast tops estimates
A Rite Aid Corp. store in Redondo Beach, Calif., on Wednesday, April 9, 2014. Rite Aid is now positioned "to transition our strategy from turnaround to growth," chief executive John Standley said in a statement after releasing earnings figures on April 10, 2014. Credit: Bloomberg News / Patrick T. Fallon
Rite Aid Corp. rose to its highest value in a dozen years after the third-largest U.S. drugstore company provided a full-year sales forecast higher than analysts' estimates.
Rite Aid gained 11 percent to $7.12 at 11:14 a.m. on Wall Street after increasing to $7.39, its highest intraday price since Oct. 2, 2001. The shares of the Camp Hill, Pennsylvania-based company more than tripled in the 12 months through Wednesday.
Revenue for fiscal 2015 is expected to be $26 billion to $26.5 billion, Rite Aid said in a statement Thursday. That was more than analysts' average estimate of $25.8 billion. Sales for the fourth quarter ended Feb. 28 were $6.6 billion, also higher than estimates.
Rite Aid is now positioned "to transition our strategy from turnaround to growth as we more aggressively pursue opportunities to become a growing retail health care company," chief executive John Standley said in the statement.
Sarra Sounds Off Ep. 35: EI baseball, girls lacrosse and plays of the week On the latest episode of "Sarra Sounds Off," we look at East Islip baseball's inspirational comeback story, Jared Valluzzi has the plays of the week and Tess Ferguson breaks down the top defensive players in girls lacrosse.
Sarra Sounds Off Ep. 35: EI baseball, girls lacrosse and plays of the week On the latest episode of "Sarra Sounds Off," we look at East Islip baseball's inspirational comeback story, Jared Valluzzi has the plays of the week and Tess Ferguson breaks down the top defensive players in girls lacrosse.
